Trial Details
COMPLETEDBasic Information
| Clinical ID | c4290 |
|---|---|
| Identifier | NCT00739986 |
| Trial Title | Semapimod for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment Versus Placebo |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Semapimod|DRUG: Semapimod|DRUG: Placebo |
Participant Information
| Sponsor | Ferring Pharmaceuticals |
|---|---|
| City | San Diego |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2002-10 |
|---|---|
| Primary Completion Date | 2004-06 |
| Completion Date | 2004-08 |